- California: San Francisco Mayor Ed Lee (D) has endorsed a newly proposed measure, sponsored by city Supervisor Malia Cohen, that would ban the retail sale of menthol cigarettes and other flavored tobacco products. According to Cohen, the measure is designed to reduce smoking and tobacco use among minority groups and teenagers, who have been targeted in ad campaigns that promote such products (Korry, Kaiser Health News, 4/20).
- Massachusetts/Rhode Island: Boston-based Partners HealthCare may acquire Providence-based Care New England. The two not-for-profit systems have signed a letter of intent, but a final deal may take months to negotiate and must pass muster with state and federal regulators, Modern Healthcare reports. The deal would include several of Care New England's facilities, but not Memorial Hospital—that facility would be sold to Prime Healthcare Foundation, a not-for-profit community hospital system based in Ontario, California (Modern Healthcare, 4/19).
- New Mexico: Silver City-based Gila Regional Medical Center has named Taffy Arias as its next CEO. Previously, Arias was CEO of Martin General Hospital in North Carolina and CNO and interim CEO at Porter Health Care System in Indiana. She will officially assume her new role at the end of May (Haefner, Becker's Hospital Review, 4/19).
12 things CEOs need to know in 2017
The continued growth of the consumer-driven health care market threatens the durability of patient-provider relationships—and, at the same time, the push toward population health management and risk-based payment is greater than ever.
Hospitals and health systems must adopt a two-pronged strategy to respond to these pressures and serve both public payers and the private sector.
At the core of that strategy? A formula of accessible, reliable, and affordable care that wins consumer preferences and drives loyalty over time. Below, we share 12 key insights for senior executives working to create a consumer-focused health system.
Download the research brief
Next in the Daily Briefing
Who should take statins? Two guidelines differ by 9.3M people, study finds